Report Detail

Pharma & Healthcare Global Reduced Glutathione for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4677098
  • |
  • 26 February, 2026
  • |
  • Global
  • |
  • 96 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Reduced Glutathione for Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Reduced glutathione for injection is used to prevent and treat tissue cell damage caused by drugs (such as chemotherapy drugs, anti-tuberculosis drugs, psychiatric drugs, paracetamol, etc.), radiotherapy, alcohol and organophosphorus;It has a protective effect on liver damage caused by various causes.
This report is a detailed and comprehensive analysis for global Reduced Glutathione for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Reduced Glutathione for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Reduced Glutathione for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Reduced Glutathione for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Reduced Glutathione for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Reduced Glutathione for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Reduced Glutathione for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biomedica Foscama, Fuan Pharmaceutical (Group) Co., Ltd., Shenyang Shuangding Pharmaceutical Co., Ltd., Beijing Sihuan Kebao Pharmaceutical Co., Ltd., Sinopharm Group Co. Ltd., CSPC OUYI Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Reduced Glutathione for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.9g
1.2g
Market segment by Application
Hospital
Clinic
Others
Major players covered
Biomedica Foscama
Fuan Pharmaceutical (Group) Co., Ltd.
Shenyang Shuangding Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Sinopharm Group Co. Ltd.
CSPC OUYI Pharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Reduced Glutathione for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Reduced Glutathione for Injection, with price, sales quantity, revenue, and global market share of Reduced Glutathione for Injection from 2021 to 2026.
Chapter 3, the Reduced Glutathione for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Reduced Glutathione for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Reduced Glutathione for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Reduced Glutathione for Injection.
Chapter 14 and 15, to describe Reduced Glutathione for Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Reduced Glutathione for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 0.9g
    • 1.3.3 1.2g
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Reduced Glutathione for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Reduced Glutathione for Injection Market Size & Forecast
    • 1.5.1 Global Reduced Glutathione for Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Reduced Glutathione for Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Reduced Glutathione for Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Biomedica Foscama
    • 2.1.1 Biomedica Foscama Details
    • 2.1.2 Biomedica Foscama Major Business
    • 2.1.3 Biomedica Foscama Reduced Glutathione for Injection Product and Services
    • 2.1.4 Biomedica Foscama Reduced Glutathione for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Biomedica Foscama Recent Developments/Updates
  • 2.2 Fuan Pharmaceutical (Group) Co., Ltd.
    • 2.2.1 Fuan Pharmaceutical (Group) Co., Ltd. Details
    • 2.2.2 Fuan Pharmaceutical (Group) Co., Ltd. Major Business
    • 2.2.3 Fuan Pharmaceutical (Group) Co., Ltd. Reduced Glutathione for Injection Product and Services
    • 2.2.4 Fuan Pharmaceutical (Group) Co., Ltd. Reduced Glutathione for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Fuan Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
  • 2.3 Shenyang Shuangding Pharmaceutical Co., Ltd.
    • 2.3.1 Shenyang Shuangding Pharmaceutical Co., Ltd. Details
    • 2.3.2 Shenyang Shuangding Pharmaceutical Co., Ltd. Major Business
    • 2.3.3 Shenyang Shuangding Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product and Services
    • 2.3.4 Shenyang Shuangding Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shenyang Shuangding Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.4 Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
    • 2.4.1 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Details
    • 2.4.2 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Major Business
    • 2.4.3 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product and Services
    • 2.4.4 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.5 Sinopharm Group Co. Ltd.
    • 2.5.1 Sinopharm Group Co. Ltd. Details
    • 2.5.2 Sinopharm Group Co. Ltd. Major Business
    • 2.5.3 Sinopharm Group Co. Ltd. Reduced Glutathione for Injection Product and Services
    • 2.5.4 Sinopharm Group Co. Ltd. Reduced Glutathione for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sinopharm Group Co. Ltd. Recent Developments/Updates
  • 2.6 CSPC OUYI Pharmaceutical Co., Ltd.
    • 2.6.1 CSPC OUYI Pharmaceutical Co., Ltd. Details
    • 2.6.2 CSPC OUYI Pharmaceutical Co., Ltd. Major Business
    • 2.6.3 CSPC OUYI Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product and Services
    • 2.6.4 CSPC OUYI Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 CSPC OUYI Pharmaceutical Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Reduced Glutathione for Injection by Manufacturer

  • 3.1 Global Reduced Glutathione for Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Reduced Glutathione for Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Reduced Glutathione for Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Reduced Glutathione for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Reduced Glutathione for Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Reduced Glutathione for Injection Manufacturer Market Share in 2025
  • 3.5 Reduced Glutathione for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Reduced Glutathione for Injection Market: Region Footprint
    • 3.5.2 Reduced Glutathione for Injection Market: Company Product Type Footprint
    • 3.5.3 Reduced Glutathione for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Reduced Glutathione for Injection Market Size by Region
    • 4.1.1 Global Reduced Glutathione for Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Reduced Glutathione for Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Reduced Glutathione for Injection Average Price by Region (2021-2032)
  • 4.2 North America Reduced Glutathione for Injection Consumption Value (2021-2032)
  • 4.3 Europe Reduced Glutathione for Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Reduced Glutathione for Injection Consumption Value (2021-2032)
  • 4.5 South America Reduced Glutathione for Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Reduced Glutathione for Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Reduced Glutathione for Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Reduced Glutathione for Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Reduced Glutathione for Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Reduced Glutathione for Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Reduced Glutathione for Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Reduced Glutathione for Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Reduced Glutathione for Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Reduced Glutathione for Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Reduced Glutathione for Injection Market Size by Country
    • 7.3.1 North America Reduced Glutathione for Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Reduced Glutathione for Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Reduced Glutathione for Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Reduced Glutathione for Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Reduced Glutathione for Injection Market Size by Country
    • 8.3.1 Europe Reduced Glutathione for Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Reduced Glutathione for Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Reduced Glutathione for Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Reduced Glutathione for Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Reduced Glutathione for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Reduced Glutathione for Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Reduced Glutathione for Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Reduced Glutathione for Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Reduced Glutathione for Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Reduced Glutathione for Injection Market Size by Country
    • 10.3.1 South America Reduced Glutathione for Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Reduced Glutathione for Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Reduced Glutathione for Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Reduced Glutathione for Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Reduced Glutathione for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Reduced Glutathione for Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Reduced Glutathione for Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Reduced Glutathione for Injection Market Drivers
  • 12.2 Reduced Glutathione for Injection Market Restraints
  • 12.3 Reduced Glutathione for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Reduced Glutathione for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Reduced Glutathione for Injection
  • 13.3 Reduced Glutathione for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Reduced Glutathione for Injection Typical Distributors
  • 14.3 Reduced Glutathione for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Reduced Glutathione for Injection. Industry analysis & Market Report on Reduced Glutathione for Injection is a syndicated market report, published as Global Reduced Glutathione for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Reduced Glutathione for Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report